Eisaburo Sueoka

Phase II Study of SMILE Chemotherapy for Newly Diagnosed Stage IV, Relapsed, or Refractory Extranodal Natural Killer (NK)/T-Cell Lymphoma, Nasal Type: The NK-Cell Tumor Study Group Study

Motoko Yamaguchi, Yok‐Lam Kwong, Won Seog Kim et al. · Journal of Clinical Oncology · 2011 · 596 citations

Essential role of tumor necrosis factor alpha (TNF-alpha) in tumor promotion as revealed by TNF-alpha-deficient mice.

Masaru Suganuma, Sachiko Okabe, Michael W. Marino et al. · PubMed · 1999 · 303 citations

Tpa-treated Tnf-/- Mice, Immunology, Pathology +18

Treatment and survival among 1594 patients with ATL

Hiroo Katsuya, Kenji Ishitsuka, Atae Utsunomiya et al. · Blood · 2015 · 302 citations · Full text

Nodularin, a potent inhibitor of protein phosphatases 1 and 2A, is a new environmental carcinogen in male F344 rat liver.

Tetsuya Ohta, Eisaburo Sueoka, Naoko Iida et al. · PubMed · 1994 · 290 citations

Potent Inhibitor, Pathology, Cancer Biology +19

Synergistic effects of (--)-epigallocatechin gallate with (--)-epicatechin, sulindac, or tamoxifen on cancer-preventive activity in the human lung cancer cell line PC-9.

Masashi Suganuma, Sachiko Okabe, Yasuko Kai et al. · PubMed · 1999 · 237 citations

Tea Polyphenols, Chemoprevention Strategy, Immunology +20